Home  >  Products  >  BDKRB1 (bradykinin receptor B1 ) Blocking Peptide (the C terminal of BDKRB1)(100ug)
BDKRB1 (bradykinin receptor B1 ) Blocking Peptide (the C terminal of BDKRB1)(100ug)

BDKRB1 (bradykinin receptor B1 ) Blocking Peptide (the C terminal of BDKRB1)(100ug)

Supplier: Aviva Systems Biology Incorporated
Star_fadedStar_fadedStar_fadedStar_fadedStar_faded
0 reviews | Write a Review Pencil
This is a synthetic peptide designed for use in combination with anti-BDKRB1 Antibody (ARP65156_P050), made by Aviva Systems Biology. It may block above mentioned antibody from binding to its target protein in western blot and/or immunohistochecmistry under proper experimental settings. There is no guarantee for its use in other applications. Please inquire for more details.
Reactivities: Human
Presku: AAP65156
Size: 100ug
Weight: 40kDa
Gene: 623
Format: Lyophilized powder
Target: Bradykinin, a 9 aa peptide, is generated in pathophysiologic conditions such as inflammation, trauma, burns, shock, and allergy. Two types of G-protein coupled receptors have been found which bind bradykinin and mediate responses to these pathophysiologic conditions. The protein encoded by this gene is one of these receptors and is synthesized de novo following tissue injury. Receptor binding leads to an increase in the cytosolic calcium ion concentration, ultimately resulting in chronic and acute inflammatory responses. Several transcript variants encoding different isoforms have been found for this gene.
Alternative names: B1BKR; B1R; BKB1R; BKR1; BRADYB1
See Full Product Listings >